Skip to main content

On This Page

← AI Financial News

D-Wave Quantum – 2025-12-23 - Increase Confidence 6/10

2 min read $QBTS
Share

These articles are AI-generated summaries. Please check the original sources for full details.

QBTSD-Wave Quantum Inc.
$32.19+4.67 (+16.97%)
$45$33$20Sep 23Nov 6Dec 22
52W High: $44.7852W Low: $20.41Volume: 63.12M
NYSE
Prediction (1/6/2026):High: $46.75Low: $3.74Ref Price: $29.12
This chart shows historical data as of December 22, 2025. Not updated in real-time.

QBTS – Increase in Days/Weeks

D-Wave Quantum reported a gross margin of 82.8% and negative free cash flow of $45M, highlighting its high-margin but capital-intensive business model. Recent bullish analyst coverage from Jefferies and Wedbush on December 21, 2025, citing U.S. government contracts and adoption of its Advantage2 system, has reignited investor interest.

Why This Matters

Despite unprofitability and negative cash flow, D-Wave is gaining traction in strategic sectors through federal contracts and enterprise partnerships—key validation signals in the early-stage quantum computing market. With the stock still below its 52-week high of $46.75 and trading at a speculative but not yet peak valuation, positive sentiment momentum could drive short-term price appreciation even in absence of near-term profitability.

Key Insights

  • Gross Margin & Cash Flow: 82.8% gross margin shows pricing power and software-like economics, but -$45M free cash flow underscores ongoing capital needs.
  • News Impact: Jefferies and Wedbush upgrades (Dec 21) highlight real-world adoption of Advantage2 and government contracts—key catalysts for investor confidence.
  • Risk/Offset: Debt/equity of 5.93 and Beta of 1.56 signal high financial and volatility risk; potential dilution looms as funding needs persist.

Practical Implications

  • Bull Case: Sustained institutional buying and follow-up news on government or enterprise deals could push shares toward $35–$38 in 2–3 weeks.
  • Bear Case: Rising fear of dilution or broader tech sell-off could trigger pullback to $25–$27, especially if macro conditions worsen.
  • Confidence: 6/10 – Near-term momentum outweighs fundamentals temporarily, but structural risks cap upside and increase volatility.

Prediction: increase

Reference:

Continue reading

Next article

Regencell Bioscience – 2025-12-23 - Increase Confidence 6/10

Related Content